{"id":"hantavax-injection","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or erythema"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL2108760","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains inactivated hantavirus antigens that trigger both humoral and cellular immune responses. Upon exposure to wild-type hantavirus, the pre-existing antibodies and memory immune cells provide protection against infection and disease progression. This is a prophylactic immunization approach rather than a direct molecular targeting mechanism.","oneSentence":"Hantavax is an inactivated vaccine that stimulates the immune system to produce antibodies against hantavirus, preventing infection with hantaviruses that cause hemorrhagic fever with renal syndrome (HFRS).","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:14:49.314Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of hemorrhagic fever with renal syndrome (HFRS) caused by hantavirus infection"}]},"trialDetails":[{"nctId":"NCT02553837","phase":"PHASE3","title":"Study to Evaluate the Immunogenicity and Safety of Hantavax in Healthy Adult","status":"UNKNOWN","sponsor":"Green Cross Corporation","startDate":"2015-11","conditions":"Healthy","enrollment":317},{"nctId":"NCT02360514","phase":"PHASE3","title":"Study to Evalutate Long-term Immunity of Hantavax in High Risk Population of HFRS","status":"COMPLETED","sponsor":"Green Cross Corporation","startDate":"2007-12","conditions":"Infection","enrollment":226}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Hantavax injection","genericName":"Hantavax injection","companyName":"Green Cross Corporation","companyId":"green-cross-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Hantavax is an inactivated vaccine that stimulates the immune system to produce antibodies against hantavirus, preventing infection with hantaviruses that cause hemorrhagic fever with renal syndrome (HFRS). Used for Prevention of hemorrhagic fever with renal syndrome (HFRS) caused by hantavirus infection.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}